SENTRY THERAPEUTICS LIMITED
CAMBRIDGE

Hellopages » Cambridgeshire » South Cambridgeshire » CB22 3AT

Company number 10576720
Status Active
Incorporation Date 23 January 2017
Company Type Private Limited Company
Address BABRAHAM HALL BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, ENGLAND, CB22 3AT
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration two events have happened. The last two records are Current accounting period shortened from 31 January 2018 to 31 December 2017; Incorporation Statement of capital on 2017-01-23 GBP 2 MODEL ARTICLES ‐ Model articles adopted . The most likely internet sites of SENTRY THERAPEUTICS LIMITED are www.sentrytherapeutics.co.uk, and www.sentry-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eight years and nine months. The distance to to Shelford (Cambs) Rail Station is 3 miles; to Cambridge Rail Station is 5.2 miles; to Audley End Rail Station is 8.9 miles; to Waterbeach Rail Station is 9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Sentry Therapeutics Limited is a Private Limited Company. The company registration number is 10576720. Sentry Therapeutics Limited has been working since 23 January 2017. The present status of the company is Active. The registered address of Sentry Therapeutics Limited is Babraham Hall Babraham Research Campus Babraham Cambridge England Cb22 3at. . KERR, Simon Christopher is a Director of the company. PEEL, Michael Robert is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
KERR, Simon Christopher
Appointed Date: 23 January 2017
68 years old

Director
PEEL, Michael Robert
Appointed Date: 23 January 2017
64 years old

Persons With Significant Control

Mr Simon Christopher Kerr
Notified on: 23 January 2017
68 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

Mr Michael Robert Peel
Notified on: 23 January 2017
64 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

SENTRY THERAPEUTICS LIMITED Events

26 May 2017
Current accounting period shortened from 31 January 2018 to 31 December 2017
23 Jan 2017
Incorporation
Statement of capital on 2017-01-23
  • GBP 2
  • MODEL ARTICLES ‐ Model articles adopted